Yang Quanhe, Erickson J David
National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA.
Am J Clin Nutr. 2003 Jan;77(1):196-203. doi: 10.1093/ajcn/77.1.196.
Folic acid intake is the most important predictor of blood folate concentrations among nonpregnant women, but the reporting of folic acid-containing supplement use is subject to error.
We assessed the effect of reporting error of supplement use on blood folate concentrations.
Data from the third National Health and Nutrition Examination Survey were analyzed. Respondents to that survey were asked twice about supplement use: ie, during the household interview, to recall use in the previous month, and during the physical examination, to recall use in the previous 24 h. To examine the effect of error reporting, we classified women (aged 15-44 y) into 5 groups according to supplement use in the previous month (nonusers, those ingesting < 400 micro g/d, and those ingesting >or= 400 micro g/d) and in the 24 h before the physical examination (yes or no). We expected nonappreciable differences in red blood cell (RBC) folate concentration by status of 24-h recall within the same category of previous-month use because RBC folate reflects long-term average consumption. We calculated covariate-adjusted means of serum and RBC folate concentrations.
Among women who reported average daily use of >or= 400 micro g folic acid in the previous month, the adjusted mean RBC folate was 436.5 nmol/L (95% CI: 406.7, 466.3 nmol/L) in those who did not take the supplement in the previous 24 h and 519.7 nmol/L (95% CI: 496.2, 543.2 nmol/L) in those who did do so (P < 0.01). This significant difference indicates apparently erroneous reporting of supplement use in the previous month by some participants.
The effect of reporting error on blood folate concentrations is important in interpreting survey results, evaluating health education campaigns, and identifying populations needing special education programs.
在未怀孕女性中,叶酸摄入量是血液叶酸浓度的最重要预测指标,但含叶酸补充剂使用情况的报告可能存在误差。
我们评估了补充剂使用报告误差对血液叶酸浓度的影响。
对第三次全国健康和营养检查调查的数据进行分析。该调查的受访者被询问了两次补充剂使用情况:即在家庭访谈中,回忆前一个月的使用情况;在体格检查中,回忆前24小时的使用情况。为了研究报告误差的影响,我们根据前一个月的补充剂使用情况(非使用者、摄入<400微克/天者、摄入≥400微克/天者)以及体格检查前24小时的使用情况(是或否),将15至44岁的女性分为5组。由于红细胞叶酸反映长期平均摄入量,我们预计在同一前一个月使用类别中,根据24小时回忆情况,红细胞叶酸浓度不会有明显差异。我们计算了血清和红细胞叶酸浓度的协变量调整均值。
在前一个月报告平均每日摄入≥400微克叶酸的女性中,前24小时未服用补充剂者的调整后红细胞叶酸均值为436.5纳摩尔/升(95%置信区间:406.7,466.3纳摩尔/升),前24小时服用补充剂者的调整后红细胞叶酸均值为519.7纳摩尔/升(95%置信区间:496.2,543.2纳摩尔/升)(P<0.01)。这一显著差异表明一些参与者在前一个月补充剂使用情况的报告明显有误。
报告误差对血液叶酸浓度的影响在解释调查结果、评估健康教育活动以及确定需要特殊教育项目的人群方面很重要。